Allovir Inc (ALVR) Insider Trading
- $11,216,412.50
- $27,597,797.28
- April 22, 2024
- Brett R Hagen
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 22, 2024 | General Counsel | 757 | $0.75 | Sell | $567.75 | |
April 22, 2024 | CAO | 480 | $0.75 | Sell | $360.00 | |
April 22, 2024 | Insider | 1,857 | $0.75 | Sell | $1,392.75 | |
April 19, 2024 | CAO | 473 | $0.75 | Sell | $354.75 | |
April 19, 2024 | CEO | 9,601 | $0.75 | Sell | $7,200.75 | |
April 19, 2024 | Insider | 1,521 | $0.75 | Sell | $1,140.75 | |
April 19, 2024 | General Counsel | 626 | $0.75 | Sell | $469.50 | |
April 2, 2024 | Insider | 885 | $0.77 | Sell | $681.45 | |
April 2, 2024 | CEO | 1,533 | $0.77 | Sell | $1,180.41 | |
April 2, 2024 | General Counsel | 368 | $0.77 | Sell | $283.36 | |
April 2, 2024 | CAO | 281 | $0.77 | Sell | $216.37 | |
Feb. 8, 2024 | CAO | 11,150 | $0.67 | Sell | $7,470.50 | |
Feb. 5, 2024 | CAO | 5,792 | $0.67 | Sell | $3,880.64 | |
Feb. 5, 2024 | CEO | 41,421 | $0.67 | Sell | $27,752.07 | |
Feb. 5, 2024 | General Counsel | 8,869 | $0.67 | Sell | $5,942.23 | |
Feb. 5, 2024 | Insider | 18,331 | $0.67 | Sell | $12,281.77 | |
Jan. 23, 2024 | CEO | 9,500 | $0.67 | Sell | $6,365.00 | |
Jan. 23, 2024 | Insider | 3,205 | $0.67 | Sell | $2,147.35 | |
Jan. 23, 2024 | CAO | 901 | $0.67 | Sell | $603.67 | |
Jan. 23, 2024 | General Counsel | 1,302 | $0.67 | Sell | $872.34 | |
Jan. 4, 2024 | Insider | 961 | $0.64 | Sell | $615.04 | |
Jan. 4, 2024 | CAO | 310 | $0.64 | Sell | $198.40 | |
Jan. 4, 2024 | General Counsel | 424 | $0.64 | Sell | $271.36 | |
Jan. 4, 2024 | CEO | 1,664 | $0.64 | Sell | $1,064.96 | |
Nov. 20, 2023 | CEO | 4,382 | $1.69 | Sell | $7,405.58 | |
Nov. 17, 2023 | Insider | 2,490 | $1.63 | Sell | $4,058.70 | |
Nov. 17, 2023 | CEO | 2,689 | $1.63 | Sell | $4,383.07 | |
Nov. 17, 2023 | CAO | 403 | $1.63 | Sell | $656.89 | |
Oct. 19, 2023 | Insider | 1,232 | $1.58 | Sell | $1,946.56 | |
Oct. 19, 2023 | CEO | 8,581 | $1.58 | Sell | $13,557.98 | |
Oct. 19, 2023 | CAO | 358 | $1.58 | Sell | $565.64 | |
Oct. 3, 2023 | Insider | 755 | $1.98 | Sell | $1,494.90 | |
Oct. 3, 2023 | CAO | 222 | $1.98 | Sell | $439.56 | |
Oct. 3, 2023 | CEO | 1,325 | $1.98 | Sell | $2,623.50 | |
Aug. 17, 2023 | Insider | 10,516 | $2.50 | Sell | $26,290.00 | |
Aug. 17, 2023 | CEO | 11,361 | $2.50 | Sell | $28,402.50 | |
Aug. 17, 2023 | CAO | 1,653 | $2.50 | Sell | $4,132.50 | |
July 19, 2023 | Insider | 1,198 | $3.56 | Sell | $4,264.88 | |
July 19, 2023 | CEO | 8,342 | $3.56 | Sell | $29,697.52 | |
July 19, 2023 | CAO | 342 | $3.56 | Sell | $1,217.52 | |
July 5, 2023 | Insider | 2,983 | $3.05 | Sell | $9,098.15 | |
July 5, 2023 | CEO | 5,275 | $3.05 | Sell | $16,088.75 | |
June 27, 2023 | Major Shareholder | 2,930,870 | $3.75 | Buy | $10,990,762.50 | |
June 9, 2023 | CAO | 5,045 | $5.64 | Sell | $28,453.80 | |
May 18, 2023 | CEO | 4,536 | $4.21 | Sell | $19,096.56 | |
April 19, 2023 | Insider | 1,217 | $3.71 | Sell | $4,515.07 | |
April 19, 2023 | CEO | 8,408 | $3.71 | Sell | $31,193.68 | |
April 19, 2023 | CAO | 348 | $3.71 | Sell | $1,291.08 | |
Jan. 19, 2023 | CEO | 34,435 | $5.08 | Sell | $174,929.80 | |
Jan. 19, 2023 | Insider | 5,111 | $5.08 | Sell | $25,963.88 |
Insiders are both buying and selling Allovir Inc stock.
The insider traders at Allovir Inc are: Brett R Hagen, Diana Brainard, Vikas Sinha, Beek Jeroen B Van, Edward Miller, David Hallal, Agustin Melian, Ann M Leen, Juan Vera, Morana Jovan-Embiricos, Jeffrey S Bornstein, Ercem Atillasoy, John Robert Wilson, Gilead Sciences, Inc., and Beek Jeroen B. Van
The most active insider trader at Allovir Inc is Brett R Hagen with 23 trades.
David Hallal has sold the most Allovir Inc stock with a total value of $13,569,944.95.
Gilead Sciences, Inc. has bought the most Allovir Inc stock with a total value of $21,981,525.00.
The most recent insider trade for Allovir Inc was on April 22, 2024.
The single biggest insider buy for Allovir Inc was from Gilead Sciences, Inc. with a total value of $10,990,762.50 on June 27, 2023.
The single biggest insider sell for Allovir Inc was from John Robert Wilson with a total value of $6,268,062.68 on March 11, 2021.